Development of novel nanovehicles for anti-HCV/HCC therapies

This work concerns the development of a nanoparticle vector system for RNA interference,constituting a new therapeutic option applicable to viral and tumor pathologies,and possibly complementary to existing treatments.siRNA vectorisation is here based on multi layer coating of alcium phosphate nanoparticles,the multi layer being constituted of alternate coatings of modified PEI and siRNA.This system triggers a better transfection efficiency of target cells than classic techniques,as well as a functional persistence up to 9 days in vitro.RNA interference results using CPnp allowed inhibition of hepatitis C virus infection up to 99.95%,of intrinsic protein expression up to 90.5%,and of cell growth in a 3 D model mimicking an hepatic tumor up to 46.5%.These nanoparticles could be of major interest,by offering a long term action,and resolving most of the issues found in the use of siRNA in therapy.

Data and Resources

Additional Info

Field Value
Source https://theses.hal.science/tel-00998936
Author Alles, Roxane
Maintainer CCSD
Last Updated May 5, 2026, 09:50 (UTC)
Created May 5, 2026, 09:50 (UTC)
Identifier NNT: 2013STRAJ052
Language fr
Rights https://about.hal.science/hal-authorisation-v1/
contributor Interactions Virus-Hôte et Maladies Hépatiques ; Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
creator Alles, Roxane
date 2013-11-27T00:00:00
harvest_object_id f6301894-1a1e-49a4-9066-a9a070479d01
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-03-31T00:00:00
set_spec type:THESE